Creating an R&D Strategy - Harvard Business School
Apr 24, 2012 · priorities of the R&D strategy. For instance, a pharmaceutical company that “intends to win” by discovering its own first-in-class drugs should have a very different portfolio allocation than a company that is trying to win by developing follow-on drugs in already established drug classes.
Tags:
Business, Pharmaceutical, School, Strategy, Harvard business school, Harvard
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
From Strategy to Business Models and to Tactics
www.hbs.eduFrom Strategy to Business Models and to Tactics* Ramon Casadesus-Masanell† Joan Enric Ricart‡ November 2009 Abstract The notion of business model has been used by strategy scholars to refer to “the logic
Business, Form, Model, Strategy, Tactics, From strategy to business models and to tactics
Elevating Repositioning Costs: Strategy Dynamics …
www.hbs.eduElevating Repositioning Costs: Strategy Dynamics and Competitive Interactions in Grand Strategy Anoop R. Menon and Dennis A. Yao1 April 17, 2014
Cost, Dynamics, Strategy, Interactions, Competitive, Repositioning, Elevating repositioning costs, Elevating, Strategy dynamics, Strategy dynamics and competitive interactions
Sustainable eet operations: The collaborative …
www.hbs.eduChocteau, et al.: Collaborative adoption of electric vehicles 2 Most of the existing literature on eet management, including the EV adoption decision, focuses
Operations, Electric, Vehicle, Sustainable, Adoption, Sustainable eet operations, The collaborative, Collaborative, Collaborative adoption of electric vehicles
Redefining Health Care: Creating Value-Based …
www.hbs.eduProfessor Michael E. Porter Harvard Business School National Association of Chain Drug Stores Annual Meeting May 2, 2006 This presentation draws on a forthcoming book with Elizabeth Olmsted Teisberg (Redefining Health Care: Creating Value-Based Competition on Results,
Business, Health, School, Care, Redefining health care, Redefining, Harvard business school, Harvard
Climate Change in 2017: Implications for Business
www.hbs.eduClimate Change in 2017: Implications for Business 317-032 3 assessments on all aspects of climate change and its impacts, with a view of formulating realistic
Business, 2017, Implications, Change, Climate, Climate change, Climate change in 2017, Implications for business
Change Agents, Networks, and Institutions
www.hbs.edu1 Change Agents, Networks, and Institutions: A Contingency Theory of Organizational Change Julie Battilana Harvard University Harvard Business School
Business, Network, School, Change, Theory, Institutions, Organizational, Agent, Harvard business school, Harvard, Change agents, And institutions, Organizational change
Improving Corporate Governance with the …
www.hbs.eduImproving Corporate Governance with the Balanced Scorecard Governance reforms such as the Sarbanes-Oxley Act of 2002 and the SEC-approved NYSE and
Scorecard, With, Governance, Corporate, Improving, Balanced, Improving corporate governance with the, Improving corporate governance with the balanced scorecard governance
Three Perspectives On Team Learning: Outcome …
www.hbs.eduTEAM LEARNING 0 THREE PERSPECTIVES ON TEAM LEARNING: OUTCOME IMPROVEMENT, TASK MASTERY, AND GROUP PROCESS Amy C. Edmondson Harvard Business School
Business, Team, School, Perspective, Group, Learning, Outcome, Three, Harvard business school, Harvard, Three perspectives on team learning
Organizational Ambidexterity: Past, Present and Future
www.hbs.eduAmbidexterity 2 Abstract Organizational ambidexterity refers to the ability of an organization to both explore and exploit—to compete in mature technologies and markets where efficiency, control, and
Value Maximization and the Corporate Objective …
www.hbs.eduValue Maximization and the Corporate Objective Function Michael C. Jensen Harvard Business School Negotiations, Organizations, and Markets Unit Mjensen@hbs.edu
Business, Corporate, School, Value, Objectives, Maximization, Harvard business school, Harvard, Value maximization and the corporate objective
Related documents
The Pharmaceutical Industry and the Patent System
users.wfu.edupharmaceutical, chemical and biotechnology industries the patent normally equals the product, and protects the extensive investment in research and clinical testing required ... Whatever patent strategy is employed by the inventor, the aim is always the same – to
Glossary of Pharmaceutical Terms and Acronyms
www.nera.comREMS: Risk Evaluation and Mitigation Strategy. A post-approval monitoring program required by the FDA for certain drugs. Sampling: Practice by which pharmaceutical companies and affiliates provide health care practitioners with free samples of …
chapter 1 Pharmaceutical solutions for oral administration
www.pharmpress.comPharmaceutical solutions for oral administration are ... Therefore, a common formulation strategy involves the selection of a pH value for the formulation that optimises the ionisation and hence solubility of the therapeutic agent. Control of the pH in the formulation is achieved using a buffer that does
Guideline on water for pharmaceutical use - CxMP adopted
www.ema.europa.euThis document is intended to provide guidance to the industry on the pharmaceutical use of different grades of water in the manufacture of active substances and medicinal products for human and veterinary use and should be considered …
Pharmaceutical supply chains: key issues and strategies ...
cepac.cheme.cmu.eduPharmaceutical supply chains: key issues and strategies for optimisation Nilay Shah∗ Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College of Science, Technology and Medicine, London SW7 2BY, UK Abstract Supply chain optimisation is now a major research theme in process operations and management.
Pharmaceutical, Strategies, Supply, Chain, Issue, Optimisation, Key issues, Pharmaceutical supply chains, Key issues and strategies for optimisation